Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Biomarkers to Predict the Efficacy of IL-4R Monoclonal Antibody（CM310） for Chronic Rhino-sinusitis With Polyps

NCT05428410 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT05428410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05428410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Biomarkers to Predict the Efficacy of IL-4R Monoclonal Antibody（CM310） for Chronic Rhino-sinusitis With Polyps
Lead sponsor
Beijing Tongren Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 17, 2022
Completion date
June 1, 2023
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker, chronic rhino-sinusitis, il-4r, monoclonal antibody